Cain K, Holt D E
Chem Biol Interact. 1983 Feb;43(2):223-37. doi: 10.1016/0009-2797(83)90097-2.
The renal uptake and degradation of cadmium-thionein (Cd-Mt) were examined in relation to nephrotoxic effects. Studies with Cd-Mt labelled with [3H]cystine showed that both Cd2+ and tritium uptake in the kidneys were complete 4 h after injection. During this period, renal copper content doubles due to the replacement of thionein-bound Cd2+ with Cu2+. This process probably occurs in the blood, prior to metallothionein uptake. Once reabsorbed, the protein is rapidly degraded in the lysosomes at a rate in step with uptake. Consequently, at 4 h virtually all of the Cd-Mt was degraded, resulting in a high concentration of non-thionein bound Cd2+. This Cd2+ (approx. 11-12 micrograms Cd2+/g, i.e. 70% of the total renal Cd2+ burden) produces the toxic effects. Between 2-4 h, new thionein synthesis is initiated and Cd2+ gradually becomes bound as the metallothionein. By 4 days, 80% of the renal Cd2+ is bound to endogenous thionein. These studies demonstrate that even small amounts of non-thionein bound Cd2+ are toxic to the kidney.
研究了镉硫蛋白(Cd-Mt)的肾脏摄取和降解及其肾毒性作用。用[3H]胱氨酸标记的Cd-Mt进行的研究表明,注射后4小时肾脏中Cd2+和氚的摄取均已完成。在此期间,由于Cu2+取代了硫蛋白结合的Cd2+,肾脏铜含量增加了一倍。这个过程可能在金属硫蛋白摄取之前于血液中发生。一旦被重吸收,该蛋白在溶酶体中迅速降解,降解速率与摄取速率同步。因此,在4小时时,几乎所有的Cd-Mt都已降解,导致非硫蛋白结合的Cd2+浓度升高。这种Cd2+(约11 - 12微克Cd2+/克,即肾脏总Cd2+负荷的70%)产生毒性作用。在2 - 4小时之间,新的硫蛋白合成开始,Cd2+逐渐与金属硫蛋白结合。到4天时,80%的肾脏Cd2+与内源性硫蛋白结合。这些研究表明,即使少量的非硫蛋白结合的Cd2+也对肾脏有毒性。